Preeclampsia in low and middle income countries-health services lessons learned from the PRE-EMPT (PRE-Eclampsia-Eclampsia Monitoring, Prevention and Treatment) project.

[1]  S. Chalupka.  Associations of Dietary Calcium Intake and Calcium Supplementation with Myocardial Infarction, Stroke, and Overall Cardiovascular Mortality , 2012 .

[2]  Brad Vogus.  LibGuides: Government Documents - Executive Branch - Department of Health and Human Services: Health Resources and Services Administration , 2012 .

[3]  L. Magee,et al.  Random urine albumin:creatinine ratio in high-risk pregnancy - Is it clinically useful? , 2012, Pregnancy hypertension.

[4]  A. Nakimuli,et al.  OS037. Minipiers (pre-eclampsia integrated estimate of risk):Development of a clinical prediction model for use in low and middleincome countries (LMIC). , 2012, Pregnancy Hypertension.

[5]  Tigest Tamrat,et al.  Special Delivery: An Analysis of mHealth in Maternal and Newborn Health Programs and Their Outcomes Around the World , 2012, Maternal and Child Health Journal.

[6]  D. Chou,et al.  The prevalence of maternal near miss: a systematic review , 2012, BJOG : an international journal of obstetrics and gynaecology.

[7]  L. Magee,et al.  The PIERS experience: research or quality improvement? , 2012, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.

[8]  L. Poston,et al.  The Role of Oxidative Stress and Antioxidant Supplementation in Pregnancy Disorders , 2017 .

[9]  J. Hutcheon,et al.  Abnormal liver function tests as predictors of adverse maternal outcomes in women with preeclampsia. , 2011, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.

[10]  Helen Wilkinson,et al.  Saving Mothers’ Lives. Reviewing maternal deaths to make motherhood safer: 2006–2008 , 2011, BJOG : an international journal of obstetrics and gynaecology.

[11]  D. Kaye,et al.  Systematic review of the magnitude and case fatality ratio for severe maternal morbidity in sub-Saharan Africa between 1995 and 2010 , 2011, BMC pregnancy and childbirth.

[12]  J. Hutcheon,et al.  The role of platelet counts in the assessment of inpatient women with preeclampsia. , 2011, Journal of Obstetrics and Gynaecology Canada.

[13]  M. Merialdi,et al.  Pre-eclampsia in low and middle income countries. , 2011, Best practice & research. Clinical obstetrics & gynaecology.

[14]  L. Magee,et al.  Assessment, surveillance and prognosis in pre-eclampsia. , 2011, Best practice & research. Clinical obstetrics & gynaecology.

[15]  J. Hutcheon,et al.  Using clinical symptoms to predict adverse maternal and perinatal outcomes in women with preeclampsia: data from the PIERS (Pre-eclampsia Integrated Estimate of RiSk) study. , 2011, Journal of Obstetrics and Gynaecology Canada.

[16]  Ziguang Qu,et al.  Oxygen saturation as a predictor of adverse maternal outcomes in women with preeclampsia. , 2011, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.

[17]  R. Romero,et al.  Supplementation with vitamins C and E during pregnancy for the prevention of preeclampsia and other adverse maternal and perinatal outcomes: a systematic review and metaanalysis. , 2011, American journal of obstetrics and gynecology.

[18]  Z. Bhutta,et al.  PIERS proteinuria: relationship with adverse maternal and perinatal outcome. , 2011, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.

[19]  J. Neilson,et al.  Saving Mothers’ Lives: Reviewing maternal deaths to make motherhood safer: 2006–2008 , 2011, BJOG : an international journal of obstetrics and gynaecology.

[20]  J. Hutcheon,et al.  Prediction of adverse maternal outcomes in pre-eclampsia: development and validation of the fullPIERS model , 2011, The Lancet.

[21]  D. Chou,et al.  Magnesium sulphate versus diazepam for eclampsia. , 2010, The Cochrane database of systematic reviews.

[22]  R. Liston,et al.  The Active Implementation of Pregnancy Hypertension Guidelines in British Columbia , 2010, Obstetrics and gynecology.

[23]  M. Mugglestone,et al.  Management of hypertensive disorders during pregnancy: summary of NICE guidance , 2010, BMJ : British Medical Journal.

[24]  L. Duley,et al.  Alternative magnesium sulphate regimens for women with pre-eclampsia and eclampsia. , 2010, The Cochrane database of systematic reviews.

[25]  T. Cole,et al.  Effect of calcium supplementation in pregnancy on maternal bone outcomes in women with a low calcium intake123 , 2010, The American journal of clinical nutrition.

[26]  M. Lindheimer,et al.  Interpreting Abnormal Proteinuria in Pregnancy: The Need for a More Pathophysiological Approach , 2010, Obstetrics and gynecology.

[27]  L. Magee,et al.  Control of hypertension in pregnancy , 2009, Current hypertension reports.

[28]  M. Reichenheim,et al.  Severe acute obstetric morbidity (near-miss): a review of the relative use of its diagnostic indicators , 2009, Archives of Gynecology and Obstetrics.

[29]  L. Magee,et al.  Predicting adverse outcomes in women with severe pre-eclampsia. , 2009, Seminars in perinatology.

[30]  G. Dekker,et al.  Guidelines for the management of hypertensive disorders of pregnancy 2008 , 2009, The Australian & New Zealand journal of obstetrics & gynaecology.

[31]  S. Taler,et al.  ASH Position Paper: Hypertension in Pregnancy , 2009, Journal of clinical hypertension.

[32]  L. Magee,et al.  The 24-hour urine collection: gold standard or historical practice? , 2008, American journal of obstetrics and gynecology.

[33]  L. Bowyer.  The Confidential Enquiry into Maternal and Child Health (CEMACH). Saving Mothers’ Lives: reviewing maternal deaths to make motherhood safer 2003–2005. The Seventh Report of the Confidential Enquiries into Maternal Deaths in the UK , 2008 .

[34]  M. Martel.  Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy. , 2008, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.

[35]  R. Liston,et al.  Diagnostic accuracy of urinary spot protein:creatinine ratio for proteinuria in hypertensive pregnant women: systematic review , 2008, BMJ : British Medical Journal.

[36]  J. Villar,et al.  Reducing eclampsia-related deaths—a call to action , 2008, The Lancet.

[37]  M. Merialdi,et al.  Calcium Supplementation During Pregnancy for Preventing Hypertensive Disorders Is not Associated with Changes in Platelet Count, Urate, and Urinary Protein: a Randomized Control Trial , 2008, Hypertension in pregnancy.

[38]  Á. Atallah,et al.  Dietary calcium supplementation for prevention of pre‐eclampsia and related problems: a systematic review and commentary , 2007, BJOG : an international journal of obstetrics and gynaecology.

[39]  Y. MacNab,et al.  Instituting Surveillance Guidelines and Adverse Outcomes in Preeclampsia , 2007, Obstetrics and gynecology.

[40]  Y. MacNab,et al.  Current CHS and NHBPEP Criteria for Severe Preeclampsia Do Not Uniformly Predict Adverse Maternal or Perinatal Outcomes , 2007, Hypertension in pregnancy.

[41]  A Metin Gülmezoglu,et al.  WHO analysis of causes of maternal death: a systematic review , 2006, The Lancet.

[42]  José Villar,et al.  World Health Organization randomized trial of calcium supplementation among low calcium intake pregnant women. , 2006, American journal of obstetrics and gynecology.

[43]  R. Ness,et al.  Uric Acid Is as Important as Proteinuria in Identifying Fetal Risk in Women With Gestational Hypertension , 2005, Hypertension.

[44]  B. Carleton,et al.  Therapy with both magnesium sulfate and nifedipine does not increase the risk of serious magnesium-related maternal side effects in women with preeclampsia. , 2005, American journal of obstetrics and gynecology.

[45]  L. Magee,et al.  The complications of hypertension in pregnancy. , 2005, Minerva medica.

[46]  J. Martin,et al.  Stroke and Severe Preeclampsia and Eclampsia: A Paradigm Shift Focusing on Systolic Blood Pressure , 2005, Obstetrics and gynecology.

[47]  L. Magee,et al.  The prediction of adverse maternal outcomes in preeclampsia. , 2004, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.

[48]  L. Poston,et al.  Oxidative stress and preeclampsia: rationale for antioxidant clinical trials. , 2004, Hypertension.

[49]  A. Weindling,et al.  The confidential enquiry into maternal and child health (CEMACH) , 2003, Archives of disease in childhood.

[50]  L. Magee,et al.  Hydralazine for treatment of severe hypertension in pregnancy: meta-analysis , 2003, BMJ : British Medical Journal.

[51]  L. Magee,et al.  Subclassification of Preeclampsia , 2003, Hypertension in pregnancy.

[52]  L. Massey.  Dairy food consumption, blood pressure and stroke. , 2001, The Journal of nutrition.

[53]  Jean-Marie Moutquin,et al.  The Classification and Diagnosis of the Hypertensive Disorders of Pregnancy: Statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP) , 2001, Hypertension in pregnancy.

[54]  James J. Walker,et al.  Pre-eclampsia , 2000, The Lancet.

[55]  J. Manson,et al.  Prospective study of calcium, potassium, and magnesium intake and risk of stroke in women. , 1999, Stroke.

[56]  K. Yano,et al.  Effect of dietary calcium and milk consumption on risk of thromboembolic stroke in older middle-aged men. The Honolulu Heart Program. , 1996, Stroke.

[57]  J. Villar,et al.  The relationship between calcium intake and edema-, proteinuria-, and hypertension-getosis: an hypothesis. , 1980, The American journal of clinical nutrition.

[58]  W. Mroczek,et al.  Effect of magnesium sulfate on cardiovascular hemodynamics. , 1978, Angiology.

[59]  M. Davidov,et al.  Effect of Magnesium Sulfate On Cardiovascular Hemodynamics , 1977 .

[60]  R. Hamlin.  The prevention of eclampsia and pre-eclampsia. , 1952, Lancet.

[61]  Henderson-Smart Dj,et al.  Magnesium sulphate versus phenytoin for eclampsia (Review) , 2007 .

[62]  G. ter Riet,et al.  Methods of prediction and prevention of pre-eclampsia: systematic reviews of accuracy and effectiveness literature with economic modelling. , 2008, Health technology assessment.

[63]  L. Magee,et al.  Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy. , 2014, Pregnancy hypertension.

[64]  Cemach.  Saving mothers' lives: reviewing maternal deaths to make motherhood safer - 2003-2005 , 2007 .

[65]  D. Henderson-smart,et al.  Magnesium sulphate and other anticonvulsants for women with pre-eclampsia. , 2003, The Cochrane database of systematic reviews.

[66]  Á. Atallah,et al.  Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems. , 2002, The Cochrane database of systematic reviews.

[67]  L. Duley,et al.  Magnesium sulphate versus lytic cocktail for eclampsia. , 2001, The Cochrane database of systematic reviews.

[68]  P. Allhoff,et al.  The Honolulu Heart Program , 1991 .

[69]  C. Lingeman.  Letter: Liver-cell neoplasms and oral contraceptives. , 1974, Lancet.